Takashi Ura
Kyoto, 6128555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Hereditary Gastric Cancer Is Linked With Hereditary Breast and Ovarian Cancer.
Journal: World journal of oncology
Published: March 18, 2024
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Journal: Medical oncology (Northwood, London, England)
Published: February 27, 2023
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: July 13, 2022
A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
Journal: International journal of radiation oncology, biology, physics
Published: March 04, 2022
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: March 17, 2021
Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.
Journal: Japanese journal of clinical oncology
Published: November 16, 2020
Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.
Journal: Japanese journal of clinical oncology
Published: November 16, 2020
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
Journal: International journal of clinical oncology
Published: June 27, 2020
Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.
Journal: The oncologist
Published: May 20, 2020
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: January 20, 2020
Last Updated: 09/26/2026